Turosteride
Alternative Names: FCE 26073Latest Information Update: 06 Aug 2002
At a glance
- Originator Pharmacia Corporation
- Class Antiandrogens; Antineoplastics
- Mechanism of Action Cholestenone 5 alpha-reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Benign prostatic hyperplasia; Prostate cancer